Business Description
Cue Biopharma Inc
NAICS : 325412
SIC : 2834
ISIN : US22978P1066
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.41 | |||||
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.38 | |||||
Debt-to-EBITDA | -0.24 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -10.85 | |||||
Beneish M-Score | -1.86 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.9 | |||||
3-Year EBITDA Growth Rate | 13.8 | |||||
3-Year EPS without NRI Growth Rate | 10.8 | |||||
3-Year FCF Growth Rate | 8.9 | |||||
3-Year Book Growth Rate | -32.9 | |||||
Future 3-5Y EPS without NRI Growth Rate | 25.48 | |||||
Future 3-5Y Total Revenue Growth Rate | 46.7 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 41.78 | |||||
9-Day RSI | 42.3 | |||||
14-Day RSI | 43.44 | |||||
6-1 Month Momentum % | -16.8 | |||||
12-1 Month Momentum % | -60.31 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.22 | |||||
Quick Ratio | 2.22 | |||||
Cash Ratio | 1.93 | |||||
Days Sales Outstanding | 74.73 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -15.9 | |||||
Shareholder Yield % | -21.82 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -478.79 | |||||
Net Margin % | -468.02 | |||||
FCF Margin % | -403.11 | |||||
ROE % | -142.28 | |||||
ROA % | -82.16 | |||||
ROIC % | -234.33 | |||||
ROC (Joel Greenblatt) % | -686.57 | |||||
ROCE % | -116.91 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.26 | |||||
PB Ratio | 2.4 | |||||
Price-to-Tangible-Book | 2.42 | |||||
EV-to-EBIT | -0.99 | |||||
EV-to-EBITDA | -1.07 | |||||
EV-to-Revenue | 4.51 | |||||
EV-to-Forward-Revenue | 5.37 | |||||
EV-to-FCF | -1.12 | |||||
Price-to-Net-Current-Asset-Value | 3.38 | |||||
Price-to-Net-Cash | 4.5 | |||||
Earnings Yield (Greenblatt) % | -101.01 | |||||
FCF Yield % | -59.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Cue Biopharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 8.725 | ||
EPS (TTM) (€) | -0.835 | ||
Beta | 0.36 | ||
Volatility % | 189.48 | ||
14-Day RSI | 43.44 | ||
14-Day ATR (€) | 0.078201 | ||
20-Day SMA (€) | 1.02425 | ||
12-1 Month Momentum % | -60.31 | ||
52-Week Range (€) | 0.314 - 2.772 | ||
Shares Outstanding (Mil) | 63.35 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cue Biopharma Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cue Biopharma Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Cue Biopharma Inc Frequently Asked Questions
What is Cue Biopharma Inc(FRA:1UC)'s stock price today?
When is next earnings date of Cue Biopharma Inc(FRA:1UC)?
Does Cue Biopharma Inc(FRA:1UC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |